Spruce’s core product is an easy-to-use iOS mobile app that lets patients submit guided intake information and photos, then receive a diagnosis and personalized treatment plan from board-certified dermatologists—typically within 24 hours. The platform supports ongoing care with 30 days of messaging per visit, follow-up visits, and care coordination when in-person attention is needed. The company recently expanded its product to support a broad set of dermatological conditions beyond acne, including eczema, psoriasis, rosacea, hair and eyelash thinning, and more. Payment is $40 per visit, with Apple Pay, major cards, HSA and FSA accepted; doctors on Spruce receive prompt payment for each visit. Spruce is available to patients 18+ in California, New York, Florida and Pennsylvania and is headquartered in San Francisco. Founded in 2013, the company says it plans to roll out its telemedicine platform to additional conditions in the future. Spruce provides a mobile dermatology telemedicine app where patients fill out intake forms, photograph skin conditions, and send them to board-certified dermatologists for assessment. The service charges $40 per assessment and aims to deliver results within 24 hours. Unlike some competitors, Spruce promises in-app treatment and includes patient follow-up plus assistance locating prescription fulfillment services (for example, nearby pharmacies). The app launched on the App Store and is initially available to patients 18+ in California, Florida, New York, and Pennsylvania. Founder Ray Bradford, a former Kleiner Perkins partner, has indicated plans to expand the technology beyond dermatology into broader telemedicine use cases. Spruce has raised seed funding to support its launch and early growth.

Total raised

$17M

Funding rounds

2

Latest round

Series A

Latest activity

Mar 2015